| abstract |
The present invention provides compounds of formula (I) and the pharmaceutically acceptable base salts thereof, wherein R is -CO2H or tetrazol-5-yl; R1 is C3-C8alkyl optionally substituted by fluoro; and R2 is C2-C4alkyl, together with compositions containing, uses of, processes for the preparation of and intermediates used in the preparation of, such compounds. The compounds have steroid 5α-reductase inhibitory activity and are useful for treating a disease such as benign prostatic hypertrophy. |